November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Sam Klempner: DKN-01 with Tislelizumab and Chemotherapy in Advanced Gastric or GEJ Adenocarcinoma
Oct 23, 2024, 14:18

Sam Klempner: DKN-01 with Tislelizumab and Chemotherapy in Advanced Gastric or GEJ Adenocarcinoma

Sam Klempner, Associate Professor at Harvard Medical School, shared on X:

“Adding to the ever growing approaches in GEA

DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or GEJ Adenocarcinoma: DisTinGuish.”

DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish

Authors: Samuel J. Klempner, Mohamad Bassam Sonbol, Zev A. Wainberg, Hope Elizabeth Uronis, Vi K. Chiu, Aaron James Scott, Syma Iqbal, Mohamedtaki Abdulaziz Tejani, Vincent Chung, Melissa C. Stilian, Mathis Thoma, Ying Zhang, Michael H. Kagey, Jason Baum, Cynthia A. Sirard, Rachel A. Altura, Jaffer A. Ajani.

Sam Klempner